Your browser doesn't support javascript.
Evaluation of mortality risk after COVID-19 vaccination, Utah 2021.
Payne, Jessica R; Bose, Srimoyee; Kubiak, Rachel W; Nolen, Leisha D.
  • Payne JR; Utah Department of Health and Human Services, Salt Lake City, UT, USA. Electronic address: jessicapayne@utah.gov.
  • Bose S; Utah Department of Health and Human Services, Salt Lake City, UT, USA.
  • Kubiak RW; Utah Department of Health and Human Services, Salt Lake City, UT, USA; CDC Foundation, Atlanta, GA, USA.
  • Nolen LD; Utah Department of Health and Human Services, Salt Lake City, UT, USA.
Vaccine ; 41(18): 2996-3002, 2023 05 02.
Article in English | MEDLINE | ID: covidwho-2301624
ABSTRACT

INTRODUCTION:

In order to evaluate trends in death after COVID-19 vaccination we analyzed the timing of death relative to vaccination date and the causes of death in vaccinated Utahns in 2021.

METHODS:

We matched people in the Utah immunization registry with documented COVID-19 vaccinations between December 18, 2020 and December 31, 2021 to Utah's 2021 vital statistics death records. Vaccinated people were categorized as having one, two, or ≥ three COVID-19 vaccine doses in a time-updated metric. We examined crude mortality rates by dosing groups in two-week intervals for all deaths, and by COVID-19 versus non-COVID-19 causes, within the 44 weeks following receipt of the most recent vaccine.

RESULTS:

We identified 2,072,908 individuals who received at least one dose of COVID-19 vaccine of whom 10,997 died in 2021. Only 17.5 % of the total vaccinated population was age 65+, while 80.9 % of those who died were over 65. In the four weeks following the first or second vaccination, all-cause mortality was low and then stabilized for the remainder of the evaluation period at a bi-weekly average of 33.0 and 39.0 deaths/100,000 people for one and two doses, respectively. Typical seasonal variation in death was observed among those with two doses. Small sample size precluded analysis of those with ≥ three doses, but trends were similar.

CONCLUSIONS:

Mortality rates in the 44 weeks following the COVID-19 vaccination did not show trends suggesting an increase in mortality related to COVID-19 vaccination, reinforcing the safety of COVID-19 vaccines. This represents an accessible approach for local evaluation.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Aged / Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Aged / Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2023 Document Type: Article